Tectonic Therapeutic (TECX) has had the highest return since January 1, 2024 by a US stock with a market cap of $2,000+, returning 6,144,900%.
| ASSET | % RETURN |
|---|---|
Tectonic Therapeutic (TECX) | 6,144,900% |
Iteris (ITI) | 5,241.28% |
TSS, Inc Common Stock (TSSI) | 3,492.59% |
GeneDx (WGS) | 2,841.85% |
Bright Minds Biosciences (DRUG) | 2,529.53% |
LENZ Therapeutics (LENZ) | 2,029.85% |
Sezzle Inc Common Stock (SEZL) | 1,875.95% |
Fitell Corporation Ordinary Shares (FTEL) | 1,676.32% |
Zivo Bioscience (ZIVO) | 1,455.56% |
Monopar Therapeutics (MNPR) | 1,150.76% |
Mobiquity Technologies (MOBQ) | 1,103.49% |
Dave (DAVE) | 1,016.93% |
Exicure (XCUR) | 989.21% |
Red Cat (RCAT) | 941.57% |
Nexalin Technology (NXL) | 919.09% |
Root (ROOT) | 850.67% |
Dogness International Corp Class A (DOGZ) | 846.35% |
Laird Superfood (LSF) | 817.09% |
Nuscale Power (SMR) | 766.05% |
Applovin (APP) | 733.7% |
Kingstone Companies (KINS) | 709.64% |
Eco Wave Power Global AB ADR (WAVE) | 667.19% |
Nano Nuclear Energy Inc Common Stock (NNE) | 643.61% |
Summit Therapeutics (SMMT) | 634.11% |
Quantum Computing (QUBT) | 626.35% |
